Connect with us

Press Releases

2020 Popular Science “Best of What’s New Awards” Recognize CooperVision MiSight

Product recognized alongside other breakthroughs that represent ‘the greatest feats of human ingenuity’ .

mm

Published

on

(PRESS RELEASE) SAN RAMON, CA — CooperVision announced that its innovative MiSigh 1 day contact lens has been awarded a 2020 Popular Science “Best of What’s New Award” in the health category. The cornerstone of CooperVision’s Brilliant Futures Myopia Management Program, this daily wear, single use contact lens is the first and only FDA-approved* product to slow the progression of myopia (nearsightedness) when initially prescribed for children 8-12 years old.[1]

The Popular Science “Best of What’s New Awards” recognize up to 100 of the most innovative technologies from the past year across 10 categories, such as health, home, aerospace and security. Each product or technology must represent a significant step forward in its category. Past award winners have included the first portable defibrillator (1997), NASA’s New Horizons Voyage to Pluto (2015), the first FDA-approved gene therapy (2017) and 5G cellular (2019).

12 Images That Show Why Zionsville Eyecare in Zionsville, IN, Was Named One of America’s Finest Optical Retailers
Photo Gallery

12 Images That Show Why Zionsville Eyecare in Zionsville, IN, Was Named One of America’s Finest Optical Retailers

These 14 Optical Conversation Pieces Leave a Lasting Impression
Photo Gallery

These 14 Optical Conversation Pieces Leave a Lasting Impression

19 Images That Will Change the Way You Think About Optical Lighting
Photo Gallery

19 Images That Will Change the Way You Think About Optical Lighting

“Two out of every five Americans have myopia,[2] a disease that both impairs distance vision and increases the risk of sight-threatening conditions later in life,”[3] explained Jerry Warner, executive vice president, Americas and Global Commercial Functions for CooperVision. “The introduction of MiSight 1 day contact lenses in the U.S. has meant that age-appropriate children, for the first time, have access to an approved solution that can help them reduce the severity of myopia progression and enjoy brilliant futures. We are honored that Popular Science has recognized the impact of this technology.”

This recognition comes as new data emerges from CooperVision’s landmark clinical study revealing that nearly one in four children’s eyes originally fit with MiSight 1 day remain stable in their myopia level after six years.[4] The study previously established the lens to be effective in slowing myopia progression in age-appropriate children by an average of 59% over a three-year period, as measured by spherical refraction.⒂1

“The Best of What’s New Awards showcase the year’s greatest feats of human ingenuity,” says Popular Science Editor-in-Chief Corinne Iozzio. “Even in a year like 2020, innovation has helped us glimpse a future that’s safer, smarter, and more enjoyable than we might have thought possible.”

More than 2,000 U.S. eye care professionals (ECPs) are now certified and able to prescribe CooperVision’s Brilliant Futures Myopia Management Program—a figure growing by the day. The widespread reach and prominence of the Popular Science “Best of What’s New Awards” will likely drive even more parents to seek information about participating ECPs.

Advertisement

CooperVision’s Brilliant Futures Myopia Management Program seeks to elevate the standard of care for age appropriate children by shifting the focus from refractive correction for myopia to interventions that also slow axial length progression. The program accomplishes this by creating the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty. ECPs who are interested in beginning certification can learn more here.

Advertisement

SPONSORED VIDEO

SPONSORED BY TOPCON HEALTHCARE

Perform Refraction from Anywhere with RDx

Now more than ever, you need to grow your practice beyond your physical location and deliver quality eye exams from virtually anywhere. Topcon RDx® is an innovative ocular telehealth platform that allows you to connect to your office remotely and conduct comprehensive eye exams, without sacrificing the quality care you provide.

Promoted Headlines

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular